E

ENCell Co Ltd
KOSDAQ:456070

Watchlist Manager
ENCell Co Ltd
KOSDAQ:456070
Watchlist
Price: 14 990 KRW -5.96% Market Closed
Market Cap: 163.4B KRW

Operating Margin

-312.6%
Current
Declining
by 52.4%
vs 3-y average of -260.2%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-312.6%
=
Operating Income
₩-18.5B
/
Revenue
₩5.9B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-312.6%
=
Operating Income
₩-18.5B
/
Revenue
₩5.9B

Peer Comparison

Country Company Market Cap Operating
Margin
KR
ENCell Co Ltd
KOSDAQ:456070
163.4B KRW
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.2T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
238.3B USD
Loading...
US
Danaher Corp
NYSE:DHR
169.4B USD
Loading...
CH
Lonza Group AG
SIX:LONN
38B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
40.9B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
281.9B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
39.2B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
29B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
20.1B EUR
Loading...
No Stocks Found

Market Distribution

Lower than 97% of companies in Korea
Percentile
3nd
Based on 2 615 companies
3nd percentile
-312.6%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

ENCell Co Ltd
Glance View

ENCell Co Ltd is a KR-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Seoul, Seoul. The company went IPO on 2024-08-23. ENCell Co Ltd is a Korea-based company principally engaged in the development and research of new drugs. The firm is principally engaged in the development and research of cell and gene-based biopharmaceuticals. The firm is also engaged in the provision of biopharmaceutical quality testing services. In addition, the Company is engaged in the biopharmaceutical consignment production business.

ENCell Co Ltd Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-312.6%
=
Operating Income
₩-18.5B
/
Revenue
₩5.9B
What is ENCell Co Ltd's current Operating Margin?

The current Operating Margin for ENCell Co Ltd is -312.6%, which is below its 3-year median of -260.2%.

How has Operating Margin changed over time?

Over the last 1 years, ENCell Co Ltd’s Operating Margin has decreased from -136.7% to -312.6%. During this period, it reached a low of -324.1% on Jun 30, 2025 and a high of -136.7% on Aug 30, 2024.

Back to Top